Israel Biotech Fund I, L.P.

Insider Reports History

Location
Rehovot, Israel
Signature
/s/ Yuval Cabilly, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Israel Biotech Fund I, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock, par value $0.001 per share 25,130,903 $10,052,361 $0.4000 07 Feb 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Warrants 13,462,500 01 Mar 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Convertible Promissory Note 11,212,500 01 Mar 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Rights 9,712,500 01 Mar 2024 Indirect

Insider Reports Filed by Israel Biotech Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000117891324000828-israel-biotech-fund-i-l-p-2024-03-01 Ayala Pharmaceuticals, Inc. 01 Mar 2024 6 $0 4 Director, 10%+ Owner 06 Mar 2024, 07:13
/report/000117891324000480-israel-biotech-fund-i-l-p-2024-02-07 Ayala Pharmaceuticals, Inc. 07 Feb 2024 14 +$4,539,287 4 Director, 10%+ Owner 12 Feb 2024, 14:16
/report/000117891323003762-israel-biotech-fund-i-l-p-2023-11-17 Ayala Pharmaceuticals, Inc. 17 Nov 2023 10 +$2,400,000 4 10%+ Owner 21 Nov 2023, 09:04
/report/000117891323003462-israel-biotech-fund-i-l-p-2023-10-18 Ayala Pharmaceuticals, Inc. 18 Oct 2023 2 $0 4 10%+ Owner 31 Oct 2023, 07:08
/report/000117891323003253-israel-biotech-fund-i-l-p-2023-09-01-restatement Ayala Pharmaceuticals, Inc. 01 Sep 2023 2 +$2,000,000 4/A 10%+ Owner 29 Sep 2023, 06:13
/report/000117891323003250-israel-biotech-fund-i-l-p-2023-01-19-restatement Ayala Pharmaceuticals, Inc. 19 Jan 2023 0 $0 3/A 10%+ Owner 29 Sep 2023, 06:10